Name:
Drotaverine tablets 40mg in cont cell pack No. 10×2
Description:
Tablets of yellow or yellow color with a greenish tinge, flat-cylindrical shape, with a chamfer. Marbling is allowed on the surface of the tablets. The main active ingredient Drotaverin Release form Tablets Dosage 40 mg Indications for use Smooth muscle spasms associated with diseases of the biliary tract: cholecystolithiasis, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis; spasms of smooth muscles of the urinary tract: nephrolithiasis, urethrolithiasis, pyelitis, cystitis, bladder tenesmus; with spasms of smooth muscles of gastrointestinal origin: peptic ulcer of the stomach and duodenum, gastritis, spasms of the cardia and pylorus, enteritis, colitis, spastic colitis with constipation and flatulence; tension headaches; in gynecology: algomenorrhea. Dosage and administrationAdults: the usual daily dose is 120-240 mg, i.e. 3-6 tablets per day, to be taken in 2-3 divided doses. A single dose for adults is 40-80 mg (1-2 tablets). The use of drotaverine in children has not been evaluated in clinical trials. In cases where taking drotaverine in children is necessary: Children 6-12 years old: the recommended daily dose for children over 6 years old is 80 mg, i.e. 2 tablets per day, which should be taken in 2 divided doses. Single dose for children 6-12 years old – 40 mg (1 tablet). Children over 12 years of age: The recommended daily dose for children over 12 years of age is 160 mg, i.e. 4 tablets per day, which should be taken in 2-4 doses. A single dose for children over the age of 12 years is 40-80 mg, i.e. 1-2 tablets. Use during pregnancy and lactationAs shown by the results of preclinical animal studies and retrospective studies of clinical data, oral administration of drotaverine during pregnancy does not lead to either teratogenic or embryotoxic effects. However, when prescribing the drug during pregnancy, caution is necessary. Due to the lack of necessary clinical data during breastfeeding, it is not recommended to prescribe. Precautions In case of hypotension, the use of the drug requires caution. The drug contains 50.3 mg of lactose monohydrate. When taken according to the recommended dosage, each dose contains up to 151 mg of lactose monohydrate. It can cause gastrointestinal complaints in individuals suffering from lactose intolerance. This form is unacceptable for patients suffering from lactose deficiency, galactosemia or impaired glucose / galactose absorption syndrome. Use in children strictly according to indications, since the use of drotaverine in this group of patients has not been sufficiently studied. Interaction with other drugs Phosphodiesterase inhibitors, like papaverine, reduce the antiparkinsonian effect of levodopa. Care must be taken when using the drug together with levodopa, since the anti-Parkinsonian effect of the latter is reduced and there is an increase in tremor and rigidity. Contraindications hypersensitivity to the active substance or to any of the excipients of the drug; severe liver or kidney failure; severe heart failure (low cardiac output); children under the age of 6 years. Composition Each tablet contains: drotaverine hydrochloride – 40 mg; excipients: potato starch, magnesium stearate, lactose monohydrate, talc. Overdose An overdose of drotaverine can cause cardiac arrhythmias and conduction disturbances, including complete blockade of the Hiss bundle legs and cardiac arrest, which can be fatal. In case of an overdose, the patient should be monitored and receive symptomatic and supportive treatment. Induction of vomiting and/or gastric lavage is recommended. Side effects During clinical trials, the following side effects were reported by researchers as at least possibly associated with drotaverine, and represented the following frequency of manifestations: very common (> 1/10); common (> 1/100, < 1/10); uncommon (> 1/1000, < 1/100); rare (> 1/10000, < 1/1000); very rare (< 1/10000), and classified according to the following organ systems: From the gastrointestinal tract Rare: nausea, constipation; From the side of the nervous system Rarely: headache, dizziness, insomnia; From the side of the cardiovascular system Rarely: palpitations, hypotension; Immune system disorders: Rare: allergic reaction (angioedema, urticaria, rash, itching). Storage conditions In a place protected from moisture and light at a temperature not exceeding 25 ° C. Keep out of the reach of children. Buy Drotaverine pills 40mg No. 10x2 Price for Drotaverine pills 40mg No. 10x2
INN | DROTAVERIN |
---|---|
The code | 102 769 |
Barcode | 4 812 608 000 018 |
Active substance | Drotaverine |
Manufacturer | Lekpharm SOOO, Belarus |
Be the first to review “Drotaverine tablets 40mg №10×2” Cancel reply
Related products
Gastrointestinal tract
Drotaverine g / x solution for injection 20mg / ml amp 2ml cont ball pack No. 5×1
$8.00
Gastrointestinal tract
Drotaverine solution for intravenous and intramuscular injection 20mg/ml in ampoules 2ml №10
$8.00
Reviews
There are no reviews yet.